More than one million older people in England will be invited to get vaccines for respiratory syncytial virus (RSV), with ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

This nasty illness can develop into severe lung infections like pneumonia or other life-threatening conditions, with the elderly most vulnerable ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Health officials have warned that people need to be protected against respiratory syncytial virus (RSV) by the vaccine.

The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...

Respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV) are leading to many people being ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...